# Fine-resolution mapping of micro vasculature after placental transport of acoustic nanodrops

> **NIH NIH R21** · RIVERSIDE RESEARCH INSTITUTE · 2020 · $205,356

## Abstract

Project Summary/Abstract
A fundamental question in developmental biology is how speciﬁc molecules and genetic pathways control mor-
phogenesis during embryonic development. Recent studies have shown that many of the same molecules and
genetic pathways affecting organogenesis are also involved in vascular development and patterning during an-
giogenesis. A major challenge is to develop rapid, in vivo mouse-embryo imaging methods that provide the ability
to analyze organ and vascular patterning with ﬁne resolution.
The goal of this proposal is to establish the feasibility of transporting acoustic nanodrops (NDs) through the pla-
centa in order to map vasculature of the embryonic mouse, in utero, with super-resolution, plane-wave ultrasonic
imaging. Perﬂuorocarbon NDs can be vaporized by an acoustic excitation and converted to gas ﬁlled acoustic
contrast agents. After vaporization, the NDs reach a size on the order of 1  m and appear as bright points in an
ultrasound image. We will formulate ND compositions of different size, charge and perﬂuorocarbon core. We will
evaluate ﬂuorescent ND compositions to determine which NDs, after injection into the maternal mouse tail vein,
pass through the placenta into the embryonic circulation and select the most promising composition in terms
of size and transport efﬁciency. We will quantify the acoustic pressures at which the selected NDs vaporize.
The most promising ND in terms of vaporization threshold will be injected into the maternal tail vein of a mouse
and, after entering the embryonic circulation, the NDs will be activated with an acoustic pulse. Plane-wave ul-
trasound and super-resolution methods will then be utilized to detect and localize activated NDs at ﬁne-spatial
and -temporal resolution as they move through the embryonic circulation. Feasibility of vascular mapping in a
single plane will be evaluated. Because this approach relies on tracking point targets, the length scale that can
be resolved, on the order of 20  m, is much less than the lateral beamwidth of the 18-MHz linear-array acous-
tic ﬁeld. The ability to activate NDs that have passed through the placenta and to perform noninvasive, in utero
contrast-enhanced imaging has high potential to revolutionize the way we study organogenesis and angiogenesis
in widely utilized models of normal and abnormal embryonic development.

## Key facts

- **NIH application ID:** 9983114
- **Project number:** 5R21HD097485-02
- **Recipient organization:** RIVERSIDE RESEARCH INSTITUTE
- **Principal Investigator:** Jeffrey Ketterling
- **Activity code:** R21 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $205,356
- **Award type:** 5
- **Project period:** 2019-08-01 → 2022-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9983114

## Citation

> US National Institutes of Health, RePORTER application 9983114, Fine-resolution mapping of micro vasculature after placental transport of acoustic nanodrops (5R21HD097485-02). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/9983114. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
